Defibrillator Devices Global Market - Forecast to 2023

Published by IQ4I on 3rd April 2017 | Ref: 1005251 | This Report Is In Stock

$4950 | Single User
$6750 | Site License
$9000 | Enterprise License
$4950 | Single User
$6750 | Site License
$9000 | Enterprise License

Introduction

Defibrillator devices are class of medical devices used for delivering shock in a controlled and automated manner. These devices are mainly used for therapeutic purposes in cardiovascular critical care management, where electrical shock is required to convert patient’s abnormal heart rhythm into normal heart rhythm to revive the victim of sudden cardiac arrest. These defibrillators help in saving the life of a SCA victim, who would have few minutes lifeline and requires resuscitation to avoid situations, which would lead to serious life threatening circumstances or even sometimes to death of a patient.

Defibrillator devices market is segmented on the basis of products, applications, end-users and geography. Products are segmented into devices, consumables and servicing, whereas devices are further segmented into Implantable Cardioverter Defibrillators (ICD’s) and external defibrillators. Implantable cardioverter defibrillators are further segmented into Transvenous Implantable Cardioverter Defibrillators (T-ICD’s) and Subcutaneous Implantable Cardioverter Defibrillators (S-ICD’s), similarly external defibrillators are classified into Automated External Defibrillators (AED’s), Wearable cardioverter defibrillators and Advanced Life Support Defibrillators (ALS). Consumables are further segmented into electrode pads, battery & chargers, first aid kits and supplies/rescue kits and others including cables & data cables, carry cases or backpacks, training units, training manikins and cabinets Applications are segmented into ventricular fibrillation, ventricular tachycardia and bradycardia. End-users are further classified into hospitals, ambulatory surgical centers, homecare, public access care, pre-hospitals and others (clinics & cardiac centers & alternative care centers).

According to IQ4I analysis, the defibrillator devices global market is expected to grow at a mid to high single digit CAGR to reach ,710.8 million by 2023. Among the defibrillator devices products market implantable cardioverter defibrillators segment holds the largest share of the market and external defibrillators is expected to be the fastest growing segment. In applications market ventricular tachycardia holds the largest share of the market and ventricular fibrillation is expected to grow with a strong CAGR from 2016 to 2023. In end- users, hospitals are the largest segment and home healthcare is the fastest growing segment from 2016 to 2023. Geographically, North America is the largest market followed by Europe and Asia Pacific. The APAC region is the fastest growing region from 2016 to 2023 presenting an array of opportunities for growth and is likely to get attention of new investors in the defibrillator devices market. Growth in the Asian market is attributed to rising prevalence of lifestyle diseases and government initiatives in establishing innovative technologies and demand for sophisticated medical services.

The defibrillator devices market is expected to grow at a single high digit CAGR during 2016 to 2023. Increase in aging population and subsequent rise in incidence of cardiovascular diseases, increasing use of defibrillators in public access areas and favorable reimbursement policies are the factors driving the market growth. Increasing trend of MRI compatible defibrillators, emergence of next generation integrated ICD’s and market expansion opportunities in emerging nations are expected to offer potential opportunities.

However various factors like patient safety risks due to chances of infection and other complications while using defibrillators, lack of awareness on sudden cardiac arrests limit the growth of defibrillator devices global market. The threats for the defibrillator devices market include lack of cybersecurity in ICD’s and increasing number of defibrillator device recalls due to FDA mandates.

The defibrillator devices global market is a highly competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Some of the key players of the defibrillator devices market are Boston Scientific Corporation (U.S.), Abbott Laboratories (U.S.), Asahi Kasei Corporation (Japan), Medtronic PLC (Ireland), Philips Healthcare (Netherland), Biotronik Se & Co. Kg (Germany), Stryker Corporation (U.S.), LivaNova (U.K.) and Nihon Kohden Corporation (Japan).

The report provides an in depth market analysis of the above mentioned segments across the following regions:

• North America

• Europe

• Asia-Pacific

• Rest of the World (RoW)

Table of Contents

1 EXECUTIVE SUMMARY 22

2 INTRODUCTION 30

2.1 KEY TAKE AWAYS 30

2.2 REPORT DESCRIPTION 31

2.3 MARKETS COVERED 32

2.4 STAKEHOLDERS 34

2.5 RESEARCH METHODOLOGY 35

3 MARKET ANALYSIS 44

3.1 INTRODUCTION 44

3.2 MARKET SEGMENTATION 45

3.3 FACTORS INFLUENCING MARKET 47

3.4 REIMBURSEMENT SCENARIO 55

3.5 REGULATORY AFFAIRS 58

3.6 TECHNOLOGICAL ADVANCEMENTS AND ON GOING CLINICAL TRIALS 61

(MIM) FOR ARRYTHMIAS DIAGNOSIS 63

3.7 MODE OF OPERATION 70

3.8 PATENT ANALYSIS 75

3.9 SUPPLY CHAIN ANALYSIS 76

3.10 PORTER’S FIVE FORCE ANALYSIS 81

3.11 IMPLANTABLE CARDIOVERTER DEFIBRILLATOR V/S EXTERNAL DEFIBRILLATOR

DEVICES 86

3.12 MARKET SHARE ANALYSIS 88

ANALYSIS 91

ANALYSIS 93

SHARE ANALYSIS 95

4 DEFIBRILLATOR DEVICES GLOBAL MARKET, BY PRODUCTS 97

4.1 INTRODUCTION 97

4.2 DEVICES 101

4.3 CONSUMABLES 154

4.4 SERVICING 163

5 DEFIBRILLATOR DEVICES GLOBAL MARKET, BY APPLICATIONS 166

5.1 INTRODUCTION 166

5.2 VENTRICULAR TACHYCARDIA 169

5.3 VENTRICULAR FIBRILLATION 171

5.4 BRADYCARDIA 174

6 DEFIBRILLATOR DEVICES GLOBAL MARKET, BY END-USERS 176

6.1 INTRODUCTION 176

6.2 HOSPITALS 178

6.3 HOME HEALTHCARE PROVIDERS 180

6.4 AMBULATORY SURGICAL CENTERS 182

6.5 PUBLIC ACCESS CARE 184

6.6 PRE-HOSPITAL CARE 186

6.7 OTHERS 187

7 DEFIBRILLATOR DEVICES GLOBAL MARKET, BY GEOGRAPHY 190

7.1 INTRODUCTION 190

7.2 NORTH AMERICA 191

7.3 EUROPE 210

7.4 ASIA-PACIFIC (APAC) 234

7.5 REST OF WORLD (ROW) 258

8 COMPANY DEVELOPMENTS 276

8.1 INTRODUCTION 276

PLAYERS 276

8.2 APPROVALS 278

8.3 NEW PRODUCT LAUNCH 285

8.4 OTHER DEVELOPMENTS 290

8.5 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES 292

8.6 MERGERS & ACQUISITIONS 293

9 COMPANY PROFILES 295

9.1 ABBOTT LABORATORIES, INC (ST JUDE MEDICAL, INC.) 295

9.2 ASAHI KASEI CORPORATION (ZOLL MEDICAL CORPORATION) 304

9.3 AURORA CAPITAL GROUP (CARDIAC SCIENCE CORPORATION) 312

9.4 BOSTON SCIENTIFIC CORPORATION 317

9.5 BIOTRONIK SE & CO.KG 326

9.6 LIVANOVA (SORIN GROUP) 333

9.7 MEDTRONIC PLC 340

9.8 NIHON KOHDEN CORPORATION 350

9.9 PHILIPS HEALTHCARE 358

9.10 STRYKER CORPORATION 365

Additional Details

Publisher

IQ4I

Publisher Information

Reference

1005251 |

Number of Pages

373

Report Format

PDF

This report is published by IQ4I

Download Free Report Summary PDF

Defibrillator Devices Global Market - Forecast to 2023 [Updated: 03-04-2017] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.